Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3017312	ts-igh-d	— (—)	204	227	100.00%	Distribution not available
3017312	b-igh-d	— (—)	17	17	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Primary_lymphoid and hematopoietic malignant neoplasms

163

110.22

318.14

1.1

—

Liquid cancers

166

158.77

317.43

1.1

1.0

—

Liquid cancers, including Hilmo

167

114.20

291.22

1.1

1.0

—

Non-follicular lymphoma

96.25

180.44

1.1

1.0

—

Enlarged lymph nodes

69.37

176.35

1.2

1.0

—

Malignant neoplasm, including Hilmo

17.68

77.33

1.1

1.0

—

Malignant neoplasm

17.59

76.65

1.1

1.0

—

Malignant neoplasm

17.59

76.65

1.1

1.0

—

Malignant neoplasm, wide definition

16.92

75.20

1.1

1.0

—

Any event in cancer register

13.74

66.89

1.1

1.0

—

Solid cancers, including Hilmo

15.24

65.02

1.1

1.0

—

Solid cancers

15.78

63.79

1.1

1.0

—

Fever of other and unknown origin

11.62

60.47

1.2

1.1

—

Diffuse large B-cell lymphoma, including Hilmo

+∞

51.27

1.2

0.0

—

Diffuse large B-cell lymphoma, helper endpoint

+∞

51.27

1.2

0.0

—

Diffuse large B-cell lymphoma

+∞

51.27

1.2

0.0

—

Non-Hodgkin lymphoma, all

+∞

46.02

1.3

0.0

—

Marginal zone B-cell lymphoma, including Hilmo

+∞

41.11

1.1

0.0

—

Other medical care

6.60

38.54

1.1

—

Malignant neoplasm of skin

18.06

38.20

1.2

1.0

—

Malignant neoplasm of skin, including Hilmo

17.87

37.77

1.2

1.0

—

General symptoms and signs

6.83

36.65

1.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

18.44

36.64

1.2

1.0

—

Neoplasms

15.13

36.40

1.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

16.21

32.84

1.2

1.0

—

Marginal zone B-cell lymphoma

+∞

31.72

1.1

0.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

128

4.53

31.33

1.1

—

ILD medications: prednisolone, methylprednisolone, prednisone

4.83

30.97

1.2

1.1

—

First line medication for Crohn's disease

4.74

28.20

1.2

1.1

—

ILD medications

4.57

28.18

1.1

—

Malignant neoplasm of digestive organs, including Hilmo

16.41

28.16

1.1

1.0

—

Basal cell carcinoma

15.22

25.91

1.1

1.0

—

Basal cell carcinoma, including Hilmo

14.03

24.87

1.1

1.0

—

Follicular lymphoma, hilmo

42.10

23.65

1.1

1.0

—

Other diseases of blood and blood-forming organs, wide

7.52

21.19

1.2

1.1

—

Bacterial infection, other or unspecified

4.53

20.69

1.2

1.1

—

Bacterial infection, other or unspecified, including avohilmo

101

4.38

20.47

1.1

—

Symptoms and signs involving the skin and subcutaneous tissue

146

3.82

19.54

1.2

1.1

—

Other bacterial diseases

132

3.51

18.48

1.1

—

Localized swelling, mass and lump of skin and subcutaneous tissue

5.68

18.47

1.1

—

Other bacterial diseases, including avohilmo

130

3.41

17.62

1.1

—

Coagulation defects, purpura and other haemorrhagic conditions

7.52

16.94

1.1

—

Inflammatory bowel disease treatment related agents

126

3.26

16.49

1.1

—

Oxycodone

4.50

16.33

1.1

1.2

—

Chronic lymphocytic leukaemia, helper endpoint

+∞

15.66

1.1

0.0

—

Chronic lymphocytic leukaemia

+∞

15.66

1.1

0.0

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

+∞

15.66

1.1

0.0

—

Oral corticosteroids

126

3.21

15.38

1.2

1.1

—

Any gastric operation

6.02

15.29

1.1

—

GASTRO-related operations

6.02

15.29

1.1

—

Abnormal findings on diagnostic imaging of lung

112

3.72

14.18

1.1

—

Persons encountering health services for specific procedures and health care

126

3.09

13.94

1.1

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

136

3.33

13.87

1.1

—

Malignant neoplasm of digestive organs

14.13

13.60

1.0

—

Lymphoid leukaemia

25.90

13.36

1.1

1.0

—

Personal history of malignant neoplasm

14.07

12.73

1.1

1.0

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

+∞

12.57

1.2

0.0

—

Purpura and other haemorrhagic conditions

10.51

11.73

1.1

1.0

—

Anaemias

16.03

11.38

1.1

1.0

—

Influenza and pneumonia

144

2.74

11.28

1.2

1.1

—

Certain disorders involving the immune mechanism

5.54

11.15

1.1

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

148

2.74

11.02

1.2

1.1

—

Any death

108

3.11

10.89

1.2

1.1

—

Pneumonias (Asthma/COPD co-morbidities)

146

2.73

10.85

1.2

1.1

—

Pneumonia, organism unspecified

140

2.79

10.72

1.2

1.1

—

All pneumoniae

147

2.70

10.61

1.2

1.1

—

Malignant immunoproliferative diseases

+∞

10.46

1.5

0.0

—

ILD medications: immunosuppressive drugs

3.48

10.21

1.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

115

2.80

9.92

1.2

1.1

—

115

2.80

9.92

1.2

1.1

—

Thrombocytopenia, unspecified

13.39

9.66

1.1

1.0

—

Hepatomegaly and splenomegaly, not elsewhere classified

+∞

9.41

1.1

0.0

—

Malignant neoplasm of stomach

+∞

9.38

1.0

0.0

—

Malignant neoplasm of stomach, including Hilmo

+∞

9.38

1.0

0.0

—

Other septicaemia, including avohilmo

3.60

8.69

1.3

1.1

—

Malignant neoplasm of eye, brain and central nervous system

+∞

8.34

1.3

0.0

—

Malignant neoplasm, without specification of site, including Hilmo

+∞

8.33

1.1

0.0

—

Aplastic and other anaemias

3.08

8.03

1.1

—

Immunodeficiencies

18.43

7.60

1.1

1.0

—

Transplanted organ and tissue status

8.02

7.58

1.3

1.2

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

+∞

7.31

1.0

0.0

—

Malignant neoplasm of bone and articular cartilage, including Hilmo

+∞

7.30

1.0

0.0

—

Malignant neoplasm, without specification of site

+∞

7.30

1.0

0.0

—

Other disorders of white blood cells

20.08

7.13

1.0

—

Other septicaemia

3.37

7.09

1.3

1.1

—

Other anaemias

2.96

6.89

1.1

—

Malignant neoplasm of respiratory system and intrathoracic organs

15.21

6.83

1.2

1.0

—

Malaise and fatigue

3.76

6.62

1.0

1.1

—

Other and unspecified anaemias

2.90

6.45

1.1

—

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

12.93

6.43

1.2

1.0

—

Other autoimmune haemolytic anaemias

+∞

6.26

1.0

0.0

—

Malignant neoplasm of other connective and soft tissue

+∞

6.25

1.2

0.0

—

Malignant neoplasm of mesothelium and soft tissue

+∞

6.25

1.2

0.0

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

+∞

6.25

1.2

0.0

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

+∞

6.25

1.8

0.0

—

Other noninfective gastroenteritis and colitis

3.75

6.07

1.2

1.1

—

Septicaemia

2.96

5.99

1.3

1.1

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

171

2.18

5.79

1.2

1.1

—

Agranulocytosis

6.86

5.73

1.0

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

10.78

5.67

1.1

1.0

—

Dialysis, with operation codes

5.57

5.67

1.5

1.1

—

Syncope and collapse

3.58

5.43

1.1

—

Malignant melanoma, including Hilmo

16.02

5.41

1.0

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

8.15

5.40

1.2

1.0

—

Explicit Sepsis, including avohilmo

101

2.60

5.31

1.2

1.1

—

Malignant neoplasm of bronchus and lung

12.55

5.31

1.1

1.0

—

Malignant neoplasm of bronchus and lung, including Hilmo

12.51

5.30

1.1

1.0

—

Other diseases of intestine

4.71

5.29

1.3

1.1

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

+∞

5.23

1.0

0.0

—

Malignant neoplasm of bone and articular cartilage

+∞

5.22

1.0

0.0

—

Mantle cell lymphoma, including Hilmo

+∞

5.21

1.2

0.0

—

Malignant neoplasm of oropharynx

+∞

5.21

1.6

0.0

—

Malignant neoplasm of oropharynx, including Hilmo

+∞

5.21

1.6

0.0

—

Malignant neoplasm of small intestine, including Hilmo

+∞

5.21

1.2

0.0

—

Rare circulating lymphoid malignancy, including Hilmo

+∞

5.21

1.2

0.0

—

Multiple myeloma, including Hilmo

+∞

5.21

1.2

0.0

—

L04AD Calcineurin inhibitors

6.33

5.07

1.1

—

Benign neoplasms

119

2.15

5.05

1.1

—

Nephropathy related operations

5.43

4.90

1.4

1.1

—

Viral infections characterized by skin and mucous membrane lesions

101

2.57

4.77

1.1

—

Other skin changes

4.42

4.73

1.3

1.1

—

Zoster [herpes zoster]

4.42

4.73

1.2

1.0

—

L01XX Other antineoplastic agents

10.03

4.52

1.1

1.0

—

Noninfective enteritis and colitis

105

2.47

4.43

1.2

1.1

—

Autoimmune diseases excluding thyroid diseases

137

1.98

4.39

1.2

1.1

—

malignant neoplasm of female genital organs, including Hilmo

9.53

4.37

1.0

—

COPD differential diagnosis

2.36

4.32

1.1

—

ILD differential diagnosis

2.36

4.32

1.1

—

Autoimmune diseases excluding thyroid diseases, strict definition

135

1.97

4.30

1.2

1.1

—

malignant neoplasm of female genital organs

11.42

4.21

1.0

—

Excluding asthma or asthma-COPD overlap

2.33

4.20

1.1

—

Certain infectious and parasitic diseases

2.13

4.18

1.1

—

All kidney diseases

163

1.93

4.09

1.1

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

149

1.95

4.07

1.2

1.1

—

Other viral diseases

3.07

4.05

1.1

1.2

—

Symptoms and signs involving the digestive system and abdomen

116

1.99

4.04

1.2

1.1

—

Noninfectious colitis NAS

5.01

4.00

1.3

1.0

—

Other viral diseases, including avohilmo

2.73

3.93

1.2

1.1

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

4.45

3.93

1.1

—

Pain, not elsewhere classified

4.45

3.92

1.1

1.0

—

Explicit Sepsis

101

2.34

3.91

1.3

1.1

—

Asthma, unspecified (mode)

2.55

3.91

1.0

1.1

—

Other viral diseases, not elsewhere classified, including avohilmo

3.24

3.86

1.2

1.1

—

Asthma

2.28

3.84

1.0

1.1

—

Other pulmonary diagnosis

2.26

3.84

1.1

—

Malignant melanoma of skin, including Hilmo

12.01

3.76

1.0

—

Chronic gastritis

2.73

3.74

1.1

—

Asthma (mode)

2.25

3.64

1.0

1.1

—

Medical observation and evaluation for suspected diseases and conditions

2.20

3.55

1.1

1.2

—

Zoster [herpes zoster], including avohilmo

126

2.14

3.50

1.4

1.1

—

Persons encountering health services in other circumstances, wide

145

1.81

3.48

1.2

1.1

—

Budesonide

4.55

3.42

1.1

1.0

—

Other viral diseases, not elsewhere classified

3.74

3.37

1.2

1.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

145

1.79

3.32

1.2

1.1

—

Asthma, excluding more controls

2.19

3.31

1.0

1.1

—

Examination and observation for other reasons

2.19

3.30

1.0

1.2

—

Gastrointestinal diseases

2.51

3.30

1.1

1.0

—

Oedema, not elsewhere classified

3.66

3.29

1.2

1.1

—

Migraine without aura

3.64

3.28

1.1

—

Malignant neoplasm of breast, HER-positive

5.96

3.25

1.1

1.0

—

Diaphragmatic hernia

2.35

3.14

1.0

1.1

—

Asthma, unspecified (mode), excluding more controls

2.35

3.06

1.0

1.1

—

Malignant neoplasm of breast, ER-positive, including Hilmo

5.41

3.06

1.1

1.0

—

Rash and other nonspecific skin eruption

5.01

3.05

1.1

1.0

—

malignant neoplasm of male genital organs

7.03

3.03

1.1

1.0

—

Melanocytic naevi

2.50

3.03

1.1

—

malignant neoplasm of male genital organs, including Hilmo

7.01

3.03

1.3

1.0

—

Other disorders of the genitourinary system

3.85

2.97

1.1

1.0

—

Certain infectious and parasitic diseases, including avohilmo

2.15

2.95

1.1

—

Collagenous colitis

4.71

2.91

1.1

1.0

—

Codes for special purposes

120

2.07

2.90

1.1

—

Tramadol

107

1.91

2.90

1.1

—

Intestinal infectious diseases, including avohilmo, including avohilmo

161

1.69

2.82

1.2

1.1

—

Pleural effusion

3.34

2.80

1.0

—

Ptosis of eyelid

4.45

2.79

1.0

—

ILD, hospital admissions 1, main diag only

3.58

2.78

1.1

1.0

—

Autoimmune diseases related-to ILD

173

1.79

2.76

1.2

1.1

—

Bacterial pneumoniae

2.29

2.75

1.1

—

Covid-19 confirmed case

2.26

2.75

1.1

—

Autoimmune hepatitis, wide definition

8.35

2.75

1.0

—

COPD/asthma related infections

115

1.79

2.75

1.1

—

COPD/asthma/ILD related infections

115

1.79

2.75

1.1

—

Other ulcerative colitis

8.35

2.75

1.4

1.0

—

Any reimbursement code in KELA

2.44

2.74

1.1

—

Bronchitis

167

1.69

2.72

1.1

—

Chronic rhinitis, nasopharyngitis and pharyngitis

2.36

2.71

1.1

—

Implicit viral Sepsis

2.71

1.1

—

Viral Sepsis

2.71

1.1

—

Multiple myeloma and malignant plasma cell neoplasms

6.02

2.70

1.3

1.0

—

Drug-induced neutropenia

6.01

2.70

1.0

—

ILD, hospital admissions

3.45

2.69

1.1

1.0

—

Other interstitial pulmonary diseases

3.45

2.68

1.1

1.0

—

Interstitial lung disease endpoints

3.45

2.68

1.1

1.0

—

Interstitial lung disease

3.45

2.68

1.1

1.0

—

Gastroduodenal ulcer

2.42

2.68

1.0

1.1

—

Sarcoidosis

3.75

2.67

1.1

—

Acute pharyngitis

4.17

2.65

1.4

1.0

—

Headache

2.39

2.64

1.1

1.0

—

Renal tubulo-interstitial diseases

159

1.75

2.61

1.1

—

Acute alcohol intoxication

0.00

2.58

0.0

1.2

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

163

1.69

2.56

1.2

1.1

—

Bell's palsy

4.00

2.56

1.1

—

Malignant neoplasm of breast, HER2-negative

3.87

2.56

1.1

1.0

—

Malignant neoplasm of breast

3.87

2.56

1.1

1.0

—

Bacterial pneumonia, not elsewhere classified

2.26

2.56

1.1

—

Acute upper respiratory infections of multiple and unspecified sites

138

1.80

2.55

1.1

—

Other diseases of pericardium

7.16

2.55

1.2

1.0

—

Nonspecific lymphadenitis

5.46

2.54

1.2

1.0

—

Carcinoma in situ of skin of other and unspecified parts of face

5.46

2.54

1.0

—

Gastric ulcer

2.73

2.54

1.0

1.1

—

Other inflammation of eyelid, including avohilmo

2.13

2.54

1.1

—

Provisional assignment of new diseases of uncertain etiology

120

1.98

2.53

1.1

—

DVT of lower extremities and pulmonary embolism

107

2.05

2.53

1.1

—

Hernia of abdominal wall, postoperative

5.42

2.53

1.0

1.3

—

Asthma and allergy, excluding more controls

5.39

2.51

1.0

—

Asthma and allergy

5.39

2.51

1.0

—

Conjunctivitis (acute, non atopic)

2.49

2.50

1.4

1.1

—

Nausea and vomiting

2.59

2.49

1.1

—

Other and unspecified dermatitis

129

1.94

2.49

1.1

—

Inflammatory bowel disease

2.32

2.47

1.3

1.1

—

Disorders of eyelid, lacrimal system and orbit

162

1.72

2.47

1.1

—

Abdominal and pelvic pain

116

1.73

2.46

1.2

1.1

—

Use of other anti-dementia drugs

0.00

2.46

0.0

1.1

—

Use of memantine

0.00

2.46

0.0

1.1

—

Malignant neoplasm of prostate

5.92

2.42

1.0

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

3.60

2.40

1.1

1.0

—

Malignant neoplasm of breast, including Hilmo

3.60

2.40

1.1

1.0

—

Other inflammatory liver diseases

5.01

2.40

1.0

—

Acute lymphadenitis

6.26

2.37

1.0

1.1

—

Benign neoplasm: salivary glands, exclude unknown (D119)

4.12

2.36

1.1

1.0

—

Other pleural conditions

4.12

2.36

1.0

—

Other diseases of intestines

140

1.67

2.35

1.3

1.1

—

All influenza

2.50

2.35

1.2

1.1

—

Implicit viral Sepsis, including avohilmo

2.25

2.32

1.1

—

147

1.62

2.31

1.1

—

Implicit Sepsis

139

1.75

2.30

1.0

1.1

—

Gastro-oesophageal reflux disease

142

1.78

2.28

1.1

—

Other and unspecified disorders of skin and subcutaneous tissue

4.62

2.27

1.2

1.0

—

Other inflammation of eyelid

3.48

2.26

1.0

—

Other disorders of eye and adnexa

3.48

2.26

1.0

1.1

—

Other symptoms and signs involving the digestive system and abdomen

3.48

2.26

1.3

1.1

—

Ulcerative colitis

2.55

2.26

1.3

1.1

—

Dermatitis

152

1.80

2.26

1.1

—

Overexertion and strenuous or repetitive movements

3.89

2.25

1.4

1.1

—

Viral pneumonia

3.89

2.25

1.0

1.1

—

Convulsions, not elsewhere classified

3.84

2.22

1.0

—

Other Crohn's disease

5.56

2.21

1.2

1.1

—

Benign neoplasm of other and unspecified endocrine glands

3.34

2.18

1.0

—

Migraine without aura and triptan purchases

3.34

2.18

1.0

—

ILD, hospital admission 2, with pulmonary infections

4.29

2.15

1.2

1.0

—

Benign neoplasm of major salivary glands

3.69

2.15

1.1

1.0

—

Crohn disease

3.69

2.15

1.1

—

Asthma-related pneumonia

2.06

2.14

1.0

1.1

—

Asthma, hospital admissions 3, pneumonia

2.06

2.14

1.0

1.1

—

Asthma-related pneumonia or sepsis

2.06

2.14

1.0

1.1

—

Other or unspecified ileus, impaction or obstruction

2.62

2.13

1.0

—

Used for control exclusion in common control thyroid runs

126

1.64

2.13

1.1

—

Other disorders of lacrimal gland

2.10

2.12

1.2

1.1

—

Diabetes mellitus

179

0.48

2.11

1.1

—

Intestinal infectious diseases

179

1.62

2.09

1.2

1.1

—

Diabetes, varying definitions

179

0.49

2.09

1.1

—

Intestinal stricture

2.13

2.08

1.1

—

Implicit fungal Sepsis, including avohilmo

5.01

2.07

1.0

—

Ovarian dysfunction

5.01

2.07

1.0

—

Infections, IBD-co-morbidities

3.01

2.05

1.1

1.0

—

Bacterial pneumonia (organism specified)

1.92

2.04

1.1

—

Other extrapyramidal and movement disorders in other diseases

2.32

2.04

1.2

1.1

—

Pulmonary embolism

2.17

2.04

1.1

—

Pulmonary heart disease

2.17

2.04

1.1

—

Viral warts

4.00

2.04

1.2

1.1

—

Inflammatory diseases of the central nervous system

4.00

2.04

1.0

—

All influenza (not pneumonia)

3.08

2.01

1.4

1.1

—

Dental caries

2.31

2.01

1.1

—

Allergic asthma (mode)

2.83

2.01

1.0

—

Paralytic ileus and intestinal obstruction

2.22

2.00

1.0

1.1

—

Asthma (diagnoses ohter than nonallergic)

179

1.62

1.99

1.0

1.1

—

Type 2 diabetes

175

0.50

1.98

1.1

—

Asthma, hospital admission 2, infections

137

1.78

1.97

1.0

1.1

—

Asthma-related infections

137

1.78

1.97

1.0

1.1

—

Other heart diseases

1.97

1.96

1.1

—

ILD medications: azathioprine

3.34

1.96

1.1

—

Use of hypnotics and sedatives

152

1.58

1.96

1.2

1.1

—

L04AX Other immunosuppressants

141

1.77

1.95

1.1

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

3.50

1.95

1.0

1.1

—

Ulcer of oesophagus

4.55

1.94

1.2

1.0

—

Acute upper respiratory infections

165

1.56

1.93

1.2

1.1

—

Other complications of surgical and medical care, not elsewhere classified

3.75

1.93

1.0

—

Open wound of lower leg

2.96

1.93

1.3

1.1

—

Opioids

113

1.64

1.92

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

153

1.69

1.91

1.2

1.1

—

Erysipelas

103

1.84

1.90

1.2

1.1

—

Other diseases of pleura

104

1.84

1.89

1.0

1.2

—

Azathioprine

3.18

1.88

1.1

1.0

—

Allergic asthma (mode), excluding more controls

2.66

1.87

1.0

—

Malignant neoplasm of prostate, including Hilmo

4.92

1.86

1.0

—

Implicit Sepsis, including avohilmo

144

1.64

1.86

1.0

1.1

—

Diseases of oesophagus, stomach and duodenum

155

1.56

1.85

1.0

1.1

—

Ischaemic Stroke, excluding all haemorrhages

136

0.43

1.85

1.0

1.1

—

Fibromyalgia

3.53

1.83

1.0

—

Benign neoplasm: Adrenal gland

4.17

1.82

1.0

—

Streptococcal septicaemia, including avohilmo

4.17

1.82

1.2

1.1

—

Venous thromboembolism

139

1.73

1.81

1.1

—

Autoimmune diseases

137

1.56

1.81

1.1

—

Implicit bacterial Sepsis, including avohilmo

101

1.81

1.80

1.0

1.1

—

Other disorders of skin and subcutaneous tissue

160

1.63

1.80

1.1

—

Stroke, excluding SAH

141

0.46

1.76

1.1

—

Conjunctivitis (acute, non atopic), including avohilmo

161

1.54

1.75

1.1

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

3.34

1.74

1.0

1.2

—

Urolithiasis

1.98

1.74

1.0

1.2

—

Radiculopathy

2.50

1.73

1.0

1.1

—

Second line medication for Crohn's disease

147

1.70

1.72

1.1

—

Abnormal findings on diagnostic imaging of other body structures

2.92

1.72

1.1

—

Viral infections of the central nervous system

3.85

1.71

1.0

1.1

—

ILD, hospital admissions 3, with pneumonia sepsis

3.85

1.71

1.2

1.0

—

Benign lipomatous neoplasm of other sites/unspecified

3.85

1.71

1.0

—

Persons encountering health services for specific procedures, not carried out

3.85

1.71

1.2

1.0

—

Gonarthrosis, primary, with knee surgery

142

0.44

1.71

1.1

—

Use of donepezil

0.00

1.71

0.0

1.0

—

Acute alcohol intoxication, ICD10

0.00

1.69

0.0

1.2

—

Obesity related asthma

1.91

1.69

1.0

1.1

—

Other respiratory diseases principally affecting the interstitium

2.50

1.66

1.1

—

Chronic periodontitis, complicated

145

1.68

1.66

1.2

1.1

—

Chronic periodontitis, including avohilmo

168

1.52

1.66

1.1

—

Periodontitis

168

1.52

1.65

1.1

—

Monoamine oxidase A inhibitors

2.80

1.65

1.0

1.1

—

Chronic sinusitis

1.85

1.65

1.0

1.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

175

0.54

1.64

1.1

—

Gingivitis and periodontal diseases

135

1.53

1.64

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

145

1.58

1.63

1.0

1.1

—

Acute appendicitis

153

1.64

1.62

1.1

—

1.84

1.61

1.0

1.1

—

Other diseases of biliary tract

3.57

1.61

1.2

1.0

—

Entropion and trichiasis of eyelid

3.57

1.61

1.2

1.0

—

Myalgia

2.14

1.60

1.1

1.0

—

Acute sinusitis

102

1.78

1.60

1.1

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

123

1.72

1.60

1.3

1.1

—

Chronic apical periodontitis

162

1.49

1.59

1.1

—

Acute tubulo-interstitial nephritis

133

1.65

1.59

1.2

1.1

—

Organic, including symptomatic, mental disorders

113

0.44

1.58

1.0

1.1

—

Disorders of other endocrine glands

1.83

1.58

1.1

—

Benign neoplasm: Skin of other and unspecified parts of face

3.00

1.58

1.2

1.0

—

Urinary track infection

1.87

1.55

1.1

1.0

—

In situ neoplasms

1.85

1.55

1.1

—

Other bacterial intestinal infections, including avohilmo

2.27

1.55

1.1

—

Asthma (only as main-diagnosis)

1.76

1.54

1.0

1.1

—

1.78

1.53

1.1

—

Benign neoplasm: Parotid gland

3.34

1.52

1.2

1.0

—

Viral infections of the central nervous system, including avohilmo

3.34

1.52

1.0

1.1

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

3.34

1.52

1.0

—

Coxarthrosis, primary

153

0.49

1.52

1.3

1.1

—

Restless leg syndrome

2.59

1.51

1.1

—

Other disorders of the musculoskeletal system and connective tissue

2.59

1.51

1.0

1.1

—

Erysipelas, including avohilmo

118

1.63

1.51

1.2

1.1

—

Hydronephrosis

2.86

1.50

1.0

—

Caries of dentine

2.16

1.50

1.0

1.1

—

Lung cancer and mesothelioma

2.46

1.48

1.1

—

Type 2 diabetes, definitions combined

173

0.57

1.48

1.1

—

Type 2 diabetes, strict (exclude DM1)

173

0.57

1.48

1.1

—

Diabetes medication

181

0.58

1.48

1.1

—

Hernia

159

1.50

1.47

1.1

—

Hypothyroidism, levothyroxine purchases

3.50

1.45

1.2

1.0

—

Hypothyroidism and >3 levothyroxin purchases

3.50

1.45

1.2

1.0

—

Hypothyroidism (congenital or acquired)

3.50

1.45

1.2

1.0

—

Stroke, including SAH

146

0.49

1.45

1.1

—

Diabetes, insulin treatment (Kela reimbursement)

183

0.58

1.44

1.2

1.1

—

Pulmonary heart disease, diseases of pulmonary circulation

1.88

1.44

1.1

1.0

—

Nontoxic single thyroid nodule

3.13

1.44

1.0

—

Aortic valve malfunction, age under 60 years

3.13

1.44

1.0

1.2

—

Heartburn

3.13

1.44

1.2

1.1

—

Other embolism and thrombosis

2.73

1.43

1.2

1.1

—

Ulcerative colitis, NAS

2.73

1.43

1.3

1.1

—

Tonsillectomy and adenotomy

1.76

1.43

1.2

1.1

—

Other disorders of bone

2.31

1.42

1.3

1.1

—

Cardiovascular diseases (excluding rheumatic etc)

1.70

1.41

1.1

—

Disorders of lacrimal system

101

1.75

1.41

1.2

1.1

—

Parasetamol

1.66

1.39

1.0

1.1

—

Hypertensive diseases (excluding secondary)

1.74

1.38

1.2

1.1

—

Diagnoses used for exclusion with ILD

2.00

1.37

1.1

—

Primary gonarthrosis, bilateral

136

0.49

1.37

1.1

—

Viral warts, including avohilmo

2.20

1.36

1.1

—

Asthma (only as main-diagnosis), excluding more controls

1.71

1.36

1.0

1.1

—

Diseases of the skin and subcutaneous tissue

121

1.49

1.36

1.0

1.1

—

Sicca syndrome [Sjögren]

2.94

1.36

1.0

—

Fentanyl

2.94

1.35

1.0

—

Other acute lower respiratory infections

121

1.65

1.35

1.0

1.1

—

Factors influencing health status and contact with health services

2.26

1.34

1.2

1.1

—

Alcohol abuse, main dg, excluding more controls

0.00

1.34

0.0

1.2

—

Acute appendicitis, no complications

127

1.64

1.33

1.1

—

Lower back pain or/and sciatica

178

1.43

1.32

1.1

—

Appendicitis, broad definition

164

1.53

1.32

1.1

—

Cough

1.71

1.31

1.1

—

Mucosal proctocolitis

2.50

1.30

1.3

1.1

—

Depression medications

3.14

1.30

1.0

—

Other and unspecified polyneuropathies, also in other diseases

2.09

1.30

1.1

—

DVT of lower extremities

2.09

1.30

1.1

1.0

—

Concussion

105

0.44

1.30

1.0

1.2

—

Lyme disease

1.84

1.29

1.0

1.1

—

Lyme disease, including avohilmo

1.84

1.29

1.0

1.1

—

Disorders of continuity of bone

2.78

1.28

1.0

1.1

—

Asthma, including avohilmo

172

1.41

1.28

1.0

1.1

—

Other reaction to severe stress, and adjustment disorders

1.88

1.28

1.0

1.1

—

Diseases of appendix

165

1.52

1.27

1.1

—

Other bacterial intestinal infections

2.29

1.26

1.1

—

Bacterial intestinal infections, IBD co-morbidities

2.29

1.26

1.1

—

5-aminosalicylic acid

2.29

1.26

1.3

1.1

—

Migraine

1.71

1.26

1.1

—

Calculus of kidney and ureter

1.82

1.25

1.0

1.2

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2.29

1.25

1.0

1.1

—

2.40

1.24

1.0

1.1

—

Recurrent aphthous stomatitis , including avohilmo

2.40

1.24

1.0

—

L04AA Selective immunosuppressants

2.00

1.23

1.1

—

Iridocyclitis

2.00

1.23

1.2

1.1

—

Glucosamine medication

114

0.49

1.22

1.0

1.1

—

Appendectomy

155

1.53

1.22

1.1

—

Unspecified kidney failure

2.63

1.21

1.0

—

Cerebral palsy and other paralytic syndromes

2.63

1.21

1.2

1.1

—

Explicit bacterial Sepsis, including avohilmo

2.63

1.21

1.2

1.1

—

Other spirochaetal diseases

1.80

1.20

1.0

1.1

—

Care involving use of rehabilitation procedures

111

1.62

1.20

1.1

—

Other obstetric conditions, not elsewhere classified

2.19

1.20

1.0

1.1

—

Skin changes due to chronic exposure to nonionizing radiation

1.69

1.19

1.1

—

Polyuria

1.93

1.16

1.0

1.1

—

Phlebitis and thrombophlebitis (not including DVT)

1.93

1.16

1.2

1.1

—

Spirochaetal infections, other/unspecified, including avohilmo

1.77

1.16

1.0

1.1

—

Codeine or tramadol medication

164

1.39

1.16

1.0

1.1

—

Abnormal findings on examination of blood, without diagnosis

106

1.62

1.15

1.2

—

Other (not insulin) diabetes medications

176

0.63

1.15

1.2

1.1

—

Lung diseases due to external agents

2.50

1.15

1.0

1.1

—

Alcohol abuse, main dg

0.00

1.15

0.0

1.1

—

Delirium, not induced by alcohol and other psychoactive substances

2.49

1.15

1.0

—

Somatoform disorder

0.00

1.14

0.0

1.1

—

Implicit bacterial Sepsis

1.64

1.13

1.1

—

Acute bronchitis

1.69

1.13

1.1

—

Spondyloarthritis

2.33

1.12

1.3

1.0

—

Stomatitis and related lesions

2.00

1.12

1.0

1.1

—

Other heart diseases, wide

139

1.44

1.11

1.1

—

Speech therapy

1.96

1.11

1.0

1.1

—

Conjunctivitis

154

1.46

1.09

1.2

1.1

—

Complications of surgical and medical care, not elsewhere classified

177

1.39

1.09

1.0

1.1

—

Primary hyperparathyroidism

2.38

1.09

1.2

1.0

—

Inflammatory disease of uterus

2.38

1.09

1.0

—

Obesity, other/unspecified

1.82

1.08

1.2

1.1

—

IBD patients in KELA-register

1.95

1.08

1.3

1.1

—

Biguanides

178

0.64

1.08

1.2

1.1

—

Pain in throat and chest

127

1.44

1.08

1.1

—

Dermatitis and eczema

177

1.37

1.08

1.1

—

Early onset COPD, excluding more controls

2.19

1.08

1.6

1.1

—

Coronary atherosclerosis

131

0.58

1.07

1.1

—

Lumbar disc prolapse

124

1.49

1.06

1.1

—

Polyneuropathies and other disorders of the peripheral nervous system

1.92

1.06

1.1

—

Actinic keratosis

1.65

1.05

1.1

—

Carbimazole or st.post thyroidectomy, condition for graves disease

2.12

1.05

1.1

1.0

—

Other spirochaetal diseases, including avohilmo

1.71

1.05

1.0

1.1

—

Disorders of conjunctiva

169

1.42

1.04

1.2

1.1

—

Diseases of inner ear

139

1.51

1.04

1.2

1.1

—

Benign neoplasm of eye and adnexa

2.27

1.03

1.2

1.0

—

Disorders of muscles

2.27

1.03

1.0

—

Melanocytic naevi of trunk

2.27

1.03

1.0

1.1

—

Inguinal hernia, bilateral

2.27

1.03

1.0

1.1

—

Other disorders of patella

2.06

1.02

1.1

1.0

—

Exposure to other specified factors

182

1.41

1.01

1.1

—

Other symptoms and signs involving the nervous and musculoskeletal systems

106

0.47

1.00

1.2

1.1

—

Other specific joint derangements/joint disorders

116

1.45

0.98

1.1

—

Disorders of synovium and tendon

116

0.51

0.98

1.3

1.1

—

Seborrhoeic keratosis

1.80

0.98

1.3

1.1

—

Benign neoplasm of breast

2.18

0.98

1.0

—

Intracranial injury

150

0.56

0.98

1.0

1.1

—

Allergic rhinitis

1.86

0.97

1.0

1.1

—

Benign neoplasm: Skin of eyelid, including canthus

0.00

0.97

0.0

1.0

—

Other maternal disorders predominantly related to pregnancy

0.50

0.97

1.0

1.1

—

Diabetic maculopathy, excluding more controls

0.00

0.97

0.0

1.1

—

Schizophrenia

0.00

0.97

0.0

1.1

—

Osteopathies and chondropathies

135

1.49

0.97

1.1

—

Sleep disorders (combined)

150

1.36

0.97

1.1

—

Other diseases of liver

1.95

0.97

1.0

1.1

—

Disorders of adult personality and behaviour

1.85

0.96

1.0

1.1

—

L02BA Anti-estrogens

0.00

0.96

0.0

1.0

—

Maternal care for known or suspected abnormality of pelvic organs

1.97

0.96

1.0

1.1

—

Insomnia

166

1.38

0.96

1.0

1.1

—

Chronic lower respiratory diseases

170

1.33

0.95

1.1

—

Pure hypercholesterolaemia

130

1.42

0.95

1.1

—

Metabolic disorders

148

1.38

0.95

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

150

1.39

0.94

1.0

1.1

—

Other intervertebral disc disorders

127

1.41

0.94

1.1

—

Other diseases of upper respiratory tract

146

1.36

0.94

1.2

1.1

—

Osteoporosis

1.76

0.93

1.1

1.0

—

Dislocation, sprain and strain of joints and ligaments at neck level

2.22

0.93

1.2

1.1

—

Coxarthrosis, primary, with hip surgery

134

0.55

0.93

1.3

1.1

—

Disorders of parathyroid gland

1.87

0.92

1.1

1.0

—

Hypertension, essential

116

1.41

0.92

1.1

—

Bacterial Sepsis

103

1.52

0.92

1.1

—

Ventral hernia

1.73

0.92

1.0

1.2

—

Superficial injury of abdomen, lower back and pelvis

2.14

0.91

1.2

1.1

—

Intracranial trauma

105

0.58

0.91

1.0

1.2

—

Other disorders of eyelid

111

1.53

0.90

1.1

—

Cardiodefibrillation

101

0.49

0.89

1.0

1.1

—

Type 2 diabetes, definitions combined, including avohilmo

169

0.68

0.89

1.2

1.1

—

Heart failure, not strict

140

1.39

0.88

1.1

—

Hypertensive diseases

117

1.40

0.88

1.1

—

Hypertension

117

1.40

0.88

1.1

—

Systemic connective tissue disorders

1.65

0.87

1.2

1.1

—

Diseases of the eye and adnexa

1.43

0.87

1.1

—

Deviated nasal septum

1.64

0.87

1.5

1.1

—

Disorders of vestibular function (Vertigo)

116

1.51

0.87

1.2

1.1

—

Obstructed labour due to maternal pelvic abnormality

2.00

0.87

1.2

1.0

—

Adjustment and management of implanted device

2.00

0.87

1.3

1.1

—

Other/unspecified dorsalgia

1.58

0.86

1.1

—

Vasomotor and allergic rhinitis

1.67

0.86

1.0

1.1

—

Inflammatory bowel disease, strict (require KELA)

1.82

0.85

1.3

1.1

—

Sensorineural hearing loss

153

0.65

0.85

1.1

—

Codeine

113

1.39

0.84

1.0

1.1

—

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

1.94

0.84

1.2

1.1

—

Diverticular disease of intestine

115

1.41

0.84

1.3

1.1

—

Diseases of liver

1.59

0.84

1.0

1.1

—

Sleep disorders

170

1.34

0.81

1.0

1.1

—

Other benign neoplasms of skin

1.57

0.81

1.2

1.1

—

Behavioural syndromes associated with physiological disturbances and physical factors

173

1.33

0.81

1.0

1.1

—

Gout, strict definition

1.70

0.80

1.9

1.1

—

Herpesviral [herpes simplex] infections, including avohilmo

1.70

0.80

1.0

1.1

—

Low back pain

132

1.38

0.80

1.2

1.1

—

Peripheral artery operations in Hilmo

0.00

0.79

0.0

1.0

—

Other (seronegative) rheumatoid arthritis, wide

1.82

0.79

1.3

1.0

—

Use of pramipexole

1.67

0.78

1.0

1.1

—

Superficial injury of shoulder and upper arm

0.00

0.78

0.0

1.1

—

Superficial injury of hip and thigh

0.00

0.78

0.0

1.0

—

Hyperparathyroidism

1.80

0.78

1.2

1.0

—

Other and unspecified disorders of vitreous body

112

1.48

0.77

1.0

1.1

—

Irregular menses

1.60

0.77

1.0

—

Statin medication

113

0.65

0.77

1.1

—

Complications of labour and delivery

0.58

0.77

1.0

—

Diabetic retinopathy, excluding more controls

1.96

0.76

1.3

1.2

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1.77

0.76

1.3

1.1

—

Coxarthrosis [arthrosis of hip](FG)

112

0.61

0.76

1.3

1.1

—

Polycystic ovarian syndrome, consortium definition

1.43

0.75

1.0

—

Dysphagia

1.70

0.75

1.2

1.1

—

Personality disorders, excluding more controls

1.69

0.75

1.0

1.1

—

Inguinal or femoral hernia, bilateral

2.08

0.74

1.0

1.1

—

Personality disorders

1.67

0.74

1.0

1.1

—

Disorders of sclera, cornea, iris and ciliary body

141

1.42

0.74

1.2

1.1

—

Cardiovascular diseases

1.46

0.73

1.1

—

Retinal breaks without detachment

1.84

0.73

1.1

—

Erosion of teeth , including avohilmo

1.64

0.73

1.3

1.1

—

Other disorders of breast

2.00

0.72

1.0

—

Complications of medical and surgical care

173

1.35

0.72

1.1

—

Disorders of lipoprotein metabolism and other lipidaemias

137

1.33

0.72

1.1

—

Other systemic involvement of connective tissue

1.61

0.72

1.2

1.0

—

Dental pulpitis, including avohilmo

163

0.71

1.1

—

Acute renal failure

1.58

0.71

1.1

—

Spondylopathies (FG)

1.92

0.70

1.4

1.0

—

Voice disturbances

1.55

0.69

1.2

1.0

—

Glaucoma

144

0.65

0.69

1.2

1.1

—

Symptoms and signs involving the nervous and musculoskeletal systems

157

0.64

0.68

1.1

—

Abrasion of teeth

1.53

0.68

1.0

1.1

—

Other predominantly sexually transmitted diseases, not elsewhere classified

1.85

0.68

1.0

1.1

—

Recurrent or chronic depression

0.53

0.68

1.0

1.2

—

Nontoxic goitre/thyroid nodule

1.53

0.68

1.0

—

Gout

1.56

0.67

1.6

1.1

—

Extrapyramidal and movement disorders

102

1.47

0.67

1.2

1.1

—

Periapical abscess

120

0.58

0.67

1.1

—

Polyarthropathies

108

1.37

0.67

1.3

1.1

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1.82

0.67

1.0

1.1

—

Specific personality disorders

1.63

0.66

1.0

1.1

—

Sciatica+with lumbago

120

1.40

0.66

1.0

1.1

—

Retinal detachment with retinal break

1.79

0.66

1.0

1.1

—

Other disorders of conjunctiva

1.79

0.66

1.2

1.0

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

1.78

0.66

1.2

1.1

—

Persons with potential health hazards related to communicable diseases

1.58

0.66

1.1

—

Other antidepressants

139

1.28

0.66

1.1

—

Pain in joint

1.40

0.65

1.1

—

Meniscus derangement

101

1.38

0.65

1.3

1.1

—

Single spontaneous delivery

0.56

0.65

1.0

1.1

—

Acne, including avohilmo

1.76

0.64

1.0

1.1

—

Endometriosis of ovary

1.74

0.64

1.0

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1.73

0.64

1.0

1.1

—

Chondropathies

1.72

0.64

1.4

1.1

—

Exclusions for E4_PCOS_BROAD

1.72

0.63

1.0

1.1

—

Sleep apnoea

168

1.27

0.63

1.1

—

Other neurological diseases

165

0.70

0.63

1.0

1.1

—

All chronic kidney diseases

109

1.39

0.63

1.2

1.1

—

Transient ischemic attack

132

0.66

0.63

1.0

1.1

—

Pollen allergy

1.70

0.63

1.0

1.1

—

Other arthrosis

1.38

0.63

1.3

1.1

—

Papulosquamous disorders

102

0.59

0.62

1.5

1.1

—

Urticaria and erythema

1.55

0.62

1.0

1.1

—

Rotator cuff syndrome

118

1.34

0.61

1.3

1.1

—

Disorder of lipoprotein metabolism, unspecified

1.67

0.61

1.4

1.1

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1.67

0.61

1.4

1.1

—

Ectopic pregnancy

1.67

0.61

1.2

1.0

—

Ulcerative colitis (strict definition, require KELA)

1.67

0.61

1.4

1.1

—

Presence of other functional implants

113

0.67

0.61

1.0

1.1

—

Valvular heart disease excluding rheumatic fever

1.38

0.61

1.2

1.1

—

Diseases of the respiratory system

1.40

0.61

1.1

—

Postpartum care and examination

0.00

0.60

0.0

1.1

—

Psoriatic arthropathies, ICD10

0.00

0.60

0.0

1.2

—

Superficial injury of forearm

0.00

0.60

0.0

1.1

—

Pedal cyclist injured in other and unspecified transport accidents

0.00

0.60

0.0

1.1

—

Mental and behavioural disorders due to alcohol

134

0.64

0.60

1.1

—

Disorders of vitreous body

132

1.37

0.60

1.0

1.1

—

Endometriosis

1.61

0.60

1.1

—

Arthropathic psoriasis

0.00

0.60

0.0

1.1

—

Rosacea

0.00

0.60

0.0

1.0

—

142

0.67

0.59

1.1

—

Procreative management

1.58

0.59

1.1

—

Disorders of skin appendages

113

1.41

0.59

1.0

1.1

—

Examination and encounter for administrative purposes

0.00

0.59

0.0

1.1

—

Burns and corrosions of external body surface, specified by site

0.00

0.59

0.0

1.1

—

Cervicocranial syndrome

0.00

0.59

0.0

1.0

—

Colon adenocarcinoma, helper endpoint

0.00

0.59

0.0

1.0

—

Sulfasalazine

1.54

0.59

1.1

1.0

—

Exclusions for E4_PCOS_CONSORTIUM

1.38

0.59

1.0

1.1

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

146

0.70

0.58

1.3

1.1

—

Disorders of vitreous body and globe

132

1.36

0.58

1.0

1.1

—

Retained placenta and membranes, without haemorrhage

0.00

0.58

0.0

1.0

—

Atopic dermatitis

104

1.38

0.58

1.2

1.1

—

Functional dyspepsia

1.48

0.57

1.4

1.1

—

Special screening examination for infectious and parasitic diseases

1.68

0.57

1.2

—

Conductive and sensorineural hearing loss

153

0.74

0.56

1.1

—

Symptoms and signs involving the urinary system

152

1.29

0.56

1.0

1.1

—

Other external causes of accidental injury

100

1.30

0.56

1.2

1.1

—

Accidents

100

1.30

0.56

1.2

1.1

—

Finngen Rheumatological endpoints

144

1.26

0.55

1.3

1.1

—

Familial hypercholesterolemia

1.62

0.55

1.3

1.1

—

Acute and subacute iridocyclitis

1.62

0.55

1.3

1.1

—

Acute appendicitis, with complications

1.62

0.55

1.2

1.1

—

Atherosclerosis, excluding cerebral and coronary sclerosis

0.65

0.55

1.0

1.2

—

Sleep apnoea, including avohilmo

165

1.25

0.54

1.1

—

Covid-19 suspected case

1.58

0.54

1.2

1.1

—

Reimbursement for rheumatic diseases

141

1.34

0.54

1.2

1.1

—

Chronic diseases of tonsils and adenoids

123

0.72

0.54

1.1

—

Carpal tunnel syndrome

158

0.71

0.54

1.0

1.1

—

Heart failure and coronary heart disease

0.68

0.53

1.1

—

Substance use, excluding alcohol

1.54

0.53

1.0

1.1

—

Abnormalities of breathing

131

1.27

0.52

1.1

—

Irritable bowel syndrome

1.43

0.52

1.0

1.1

—

141

0.70

0.52

1.1

—

Shoulder lesions

127

1.27

0.52

1.2

1.1

—

Other dorsopathies, not elsewhere classified

133

1.25

0.52

1.1

—

Endometriosis ASRM stages 3,4

1.50

0.51

1.2

1.0

—

Complications of procedures, not elsewhere classified

172

1.26

0.51

1.1

—

Varicose veins

128

0.71

0.51

1.1

—

Nonsuppurative otitis media

1.49

0.51

1.0

1.1

—

Benign lipomatous neoplasm

1.47

0.50

1.0

1.1

—

Candidiasis, including avohilmo

1.38

0.50

1.0

1.1

—

Other systemic involvement of connective tissue (FG)

1.38

0.50

1.2

1.0

—

Gout, FINNGEN

1.44

0.50

1.6

1.1

—

Anterior Iridocyclitis

1.46

0.50

1.3

1.1

—

Insulin medication

149

0.72

0.50

1.2

1.1

—

Other chronic obstructive pulmonary disease, including avohilmo

138

0.71

0.50

1.3

1.1

—

Benign paroxysmal vertigo

1.49

0.49

1.3

1.1

—

All dysplastic lesions of the cervix uteri, vagina or vulva

1.55

0.48

1.1

1.0

—

Noninflammatory disorders of female genital tract

1.49

0.48

1.0

1.1

—

Benign neoplasm: Rectum

1.52

0.48

1.1

—

Disturbances of skin sensation

1.52

0.48

1.0

1.1

—

Injuries to the neck

1.49

0.47

1.1

—

Dorsalgia

133

1.23

0.47

1.1

—

Fall on same level involving ice and snow

154

0.71

0.47

1.1

—

Benign neoplasm: Rectum, anus and anal canal

1.46

0.46

1.1

—

Diabetic retinopathy

1.45

0.46

1.3

1.1

—

Other headache syndromes

102

1.37

0.46

1.1

—

Other joint disorders

117

1.25

0.46

1.1

—

Triptan medication for migraine, min. 3 purchases

1.38

0.46

1.0

1.1

—

0.61

0.46

1.0

1.1

—

Fracture of skull and facial bones

1.43

0.46

1.1

—

Coxarthrosis

0.70

0.45

1.3

1.1

—

Non-rheumatic valve diseases

1.31

0.44

1.2

1.1

—

Delivery, wide proxy

0.64

0.44

1.0

1.1

—

Paroxysmal tachycardia

1.38

0.44

1.0

1.2

—

Diseases of salivary glands

1.45

0.44

1.1

—

Nasal polyp

1.37

0.44

1.3

1.2

—

Peripheral artery disease

101

0.70

0.44

1.1

—

Injuries to the wrist and hand

190

0.80

0.43

1.0

1.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

158

0.75

0.43

1.2

1.1

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

1.62

0.43

1.0

1.1

—

Seropositive rheumatoid arthritis, strict definition

1.61

0.43

1.0

—

Injuries to the elbow and forearm

168

0.76

0.42

1.1

—

COPD, hospital admissions 1, only main diagnosis

0.63

0.42

1.0

1.1

—

Unspecified mental disorder

0.66

0.42

1.0

1.1

—

Unspecified acute lower respiratory infection

1.56

0.42

1.0

1.1

—

Alcohol use disorder, Swedish definition

137

0.73

0.42

1.1

—

COPD (mode)

1.39

0.42

1.5

1.1

—

Corneal ulcer

1.52

0.41

1.0

1.1

—

Acute laryngitis and tracheitis

0.00

0.41

0.0

1.0

—

Valvular operations

1.52

0.41

1.0

1.1

—

Undefined dementia

0.00

0.41

0.0

1.0

—

Bacterial, viral and other infectious agents

0.00

0.41

0.0

1.1

—

Other and unspecified myopathies

0.00

0.41

0.0

1.0

—

Amputation

0.00

0.41

0.0

1.0

—

Pilonidal cyst

0.00

0.41

0.0

1.1

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

0.00

0.41

0.0

1.0

—

Abscess of anal and rectal regions

0.00

0.41

0.0

1.1

—

Other diseases of arteries and capillaries

0.00

0.41

0.0

1.0

—

Other complications of labour and delivery, not elsewhere classified

0.00

0.41

0.0

1.0

—

Abdominal aortic aneurysm (AAA)

0.00

0.41

0.0

1.0

—

Alzheimer’s disease (Atypical or mixed)

0.00

0.41

0.0

1.0

—

Delivery

0.65

0.41

1.0

1.1

—

Mycoses, including avohilmo

189

1.21

0.41

1.1

—

Diabetic maculopathy

0.00

0.41

0.0

1.1

—

Fenamates

1.48

0.40

1.0

1.1

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1.38

0.40

1.1

1.0

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

0.00

0.40

0.0

1.0

—

Other and unspecified iron deficiency

1.39

0.40

1.1

—

Mycoses

1.33

0.40

1.0

1.1

—

Open wound of ankle and foot

0.00

0.40

0.0

1.1

—

Ovarian cyst

1.39

0.39

1.1

—

Unspecified dementia

0.00

0.39

0.0

1.0

—

Glaucoma suspect

103

0.68

0.39

1.3

1.1

—

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

1.43

0.39

1.0

1.1

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

1.43

0.39

1.0

1.1

—

Blepharochalasis

1.41

0.39

1.0

—

Carcinoma in situ of breast, intraductal

0.00

0.39

0.0

1.0

—

Use of disulfiram, acamprosate or naltrexone

0.00

0.39

0.0

1.2

—

Other psoriatic arthropathies

0.00

0.39

0.0

1.1

—

Psoriatic arthropathies

0.00

0.39

0.0

1.1

—

Fall on same level

167

1.18

0.38

1.1

—

Soft tissue disorders related to use, overuse and pressure

1.38

0.38

1.2

1.1

—

Selective serotonin reuptake inhibitors

139

1.20

0.38

1.0

1.1

—

Thyrotoxicosis, other and/or unspecified

1.39

0.38

1.0

—

Adverse effects, not elsewhere classified

1.39

0.38

1.8

1.1

—

Unstable angina pectoris

0.71

0.37

1.1

—

Leiomyoma of uterus

1.30

0.37

1.0

1.1

—

Other and unspecified urticaria

1.35

0.37

1.0

1.1

—

Alcohol use disorder, ICD-based

114

0.70

0.37

1.0

1.1

—

Other abnormal uterine and vaginal bleeding

1.49

0.36

1.2

1.1

—

Angina pectoris

120

0.77

0.36

1.1

—

Injuries to the shoulder and upper arm

190

0.81

0.36

1.0

1.1

—

Fitting and adjustment of other devices

1.28

0.36

1.1

—

Calcific aortic valvular stenosis, operated

1.27

0.36

1.2

1.1

—

Calcific aortic valvular stenosis

1.27

0.36

1.2

1.1

—

Calcific aortic valvular stenosis, diagnosis (helper)

1.27

0.36

1.2

1.1

—

Operations 2 for CAVS

1.27

0.36

1.2

1.1

—

Macular pucker

1.43

0.35

1.0

—

Other diseases of the respiratory system

1.43

0.35

1.2

1.1

—

Other respiratory disorders and diseases

1.43

0.35

1.2

1.1

—

Focal epilepsy

1.43

0.35

1.0

1.1

—

Kela-code for severe mental illness

0.63

0.35

1.0

1.1

—

Other hammer toe(s) (acquired)

1.40

0.35

1.0

1.1

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

123

0.72

0.35

1.1

—

Other noninflammatory disorders of uterus, except cervix

1.38

0.35

1.0

1.1

—

Temporomandibular joint disorders, including avohilmo

1.35

0.34

1.0

1.1

—

Gonarthrosis,primary

161

0.82

0.34

1.2

1.1

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1.38

0.34

1.2

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1.32

0.34

1.1

—

Symptoms and signs involving the circulatory and respiratory systems

131

1.19

0.34

1.1

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1.37

0.34

1.1

1.0

—

Hallux valgus (acquired)

1.36

0.34

1.0

1.1

—

Ischaemic heart disease, wide definition

144

0.81

0.34

1.1

—

Diseases of pulp and periapical tissues, including avohilmo

145

1.18

0.34

1.1

—

Caries of enamel

172

1.18

0.34

1.1

—

Artrosis, including avohilmo

134

0.82

0.33

1.3

1.1

—

Cardiomyopathy

1.33

0.33

1.0

1.2

—

Insulin, intermediate and long-acting

150

0.77

0.33

1.3

1.1

—

Contact with and exposure to communicable diseases

1.33

0.33

1.0

1.1

—

Other soft tissue disorders, not elsewhere classified

139

1.19

0.33

1.1

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

149

0.81

0.33

1.1

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

0.69

0.33

1.0

—

Non-ischemic cardiomyopathy

1.32

0.33

1.1

—

Other disorders of fluid, electrolyte and acid-base balance

0.70

0.33

1.3

1.1

—

Primary open-angle glaucoma

0.69

0.33

1.2

1.1

—

Persons encountering health services for examination and investigation

1.25

0.33

1.1

1.2

—

Diseases of pulp and periapical tissues and dental caries

0.79

0.32

1.1

—

Benzodiazepine use

185

1.17

0.32

1.0

1.1

—

Genitourinary diseases

1.25

0.31

1.1

1.2

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1.36

0.31

1.0

1.1

—

Disorders of choroid and retina

160

1.18

0.31

1.1

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

1.35

0.31

1.1

—

Superficial injury of head

1.34

0.31

1.0

1.1

—

Neurological diseases, wide definition

1.30

0.31

1.0

—

Non-selective monoamine reuptake inhibitors

0.72

0.31

1.0

1.2

—

Cystitis

125

1.19

0.30

1.1

—

Gout, unspecified

1.30

0.30

2.0

1.1

—

Fissure and fistula of anal and rectal regions

1.30

0.30

1.0

1.1

—

Postmenopausal atrophic vaginitis

1.27

0.30

1.0

1.1

—

Subjective visual disturbances

1.27

0.30

1.0

1.1

—

Disorders of refraction and accommodation

1.27

0.29

1.3

1.0

—

Disorders of breast

1.27

0.29

1.0

—

Asthma, hospital admissions , main diagnosis only

185

1.17

0.28

1.0

1.1

—

Symptoms and signs involving speech and voice

1.32

0.28

1.3

1.1

—

Other diseases of urinary system

140

1.16

0.28

1.1

—

Tinnitus

1.27

0.27

1.1

—

Propionic acid derivatives

0.68

0.27

1.0

1.2

—

Anti-inflammatory and antirheumatic products, non-steroids

0.68

0.27

1.0

1.2

—

Nonsuppurative otitis media, including avohilmo

1.23

0.27

1.0

1.1

—

Suppurative and unspecified otitis media

1.20

0.26

1.0

1.1

—

Gout, idiopatic and unspecified

1.19

0.26

1.9

1.1

—

Keratitis

1.28

0.26

1.0

1.1

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

0.70

0.26

1.2

1.1

—

Primary open-angle glaucoma, strict

0.69

0.26

1.0

—

Cerebrovascular diseases (FINNGEN)

1.24

0.25

1.1

1.2

—

Calcific aortic valvular stenosis, including rheumatic fever

1.25

0.25

1.2

1.1

—

Allergic conjunctivitis

118

1.22

0.25

1.0

1.1

—

Injuries to the ankle and foot

164

0.83

0.25

1.1

—

Benign thyroid growths and nodules

1.21

0.25

1.0

—

Striking against or struck by other objects

1.21

0.25

1.0

1.1

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

109

1.23

0.25

1.0

1.1

—

Diseases of the musculoskeletal system and connective tissue

1.23

0.25

1.1

—

Nerve, nerve root and plexus disorders

186

0.87

0.25

1.1

—

Type 2 diabetes, wide definition

155

0.85

0.25

1.1

—

Diseases of middle ear and mastoid

108

1.21

0.24

1.0

1.1

—

Pain (limb, back, neck, head abdominally)

1.18

0.24

1.1

—

Mental and behavioural disorders due to psychoactive substance use

145

0.82

0.23

1.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

158

1.18

0.23

1.1

—

Asthma/COPD (KELA code 203)

170

1.14

0.23

1.0

1.1

—

Dental caries, including avohilmo

109

0.85

0.23

1.1

—

Benign neoplasm of other and ill-defined parts of digestive system

1.32

0.23

1.0

1.1

—

Caries of dentine, including avohilmo

114

0.85

0.23

1.1

—

Persistent mood disorders

1.28

0.23

1.2

1.1

—

Focal epilepsy, strict definition

1.28

0.23

1.0

1.1

—

All dysplastic lesions of the cervix uteri

1.26

0.22

1.2

1.0

—

Lichen planus, including avohilmo

1.25

0.22

1.2

1.1

—

Other diseases of the digestive system

1.27

0.22

1.1

—

Dorsopathies

134

1.13

0.22

1.1

—

Complications predominantly related to the puerperium

1.22

0.22

1.0

—

Peritonsillar abscess

1.19

0.21

1.2

1.0

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

0.00

0.21

0.0

1.0

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

0.00

0.21

0.0

1.0

—

Abnormal blood-pressure reading, without diagnosis

0.00

0.21

0.0

1.0

—

Laparoscopic right hemicolectomy

0.00

0.21

0.0

1.0

—

Convalescence

0.00

0.21

0.0

1.0

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

0.00

0.21

0.0

1.0

—

Extracorporeal dialysis

0.00

0.21

0.0

1.0

—

Fracture of neck

0.00

0.21

0.0

1.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

0.00

0.21

0.0

1.0

—

Osteomyelitis

0.00

0.21

0.0

1.0

—

Psychotic depression

0.00

0.21

0.0

1.1

—

Event of undetermined intent

0.00

0.21

0.0

1.2

—

Other and unspecified glaucoma

0.00

0.21

0.0

1.0

—

Dermatographic urticaria

0.00

0.21

0.0

1.0

—

Visual impairment including blindness (binocular or monocular)

0.00

0.21

0.0

1.0

—

Invasive ventilation

0.00

0.21

0.0

1.0

—

MS-disease / Multiple Sclerosis

0.00

0.21

0.0

1.1

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

0.00

0.21

0.0

1.2

—

Other/unspecified enthesopathies of lower limb, excluding foot

0.00

0.21

0.0

1.1

—

Other and unspecified mood [affective] disorders

0.00

0.21

0.0

1.0

—

Postpartum haemorrhage due to retained placenta

0.00

0.21

0.0

1.0

—

Disorders of psychological development

0.00

0.21

0.0

1.0

—

Medial epicondylitis

0.00

0.21

0.0

1.0

—

Dystonia

0.00

0.21

0.0

1.0

—

Tongue abnormality

0.00

0.21

0.0

1.0

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

0.00

0.21

0.0

1.0

—

Decubitus ulcer and pressure area

0.00

0.21

0.0

1.0

—

Dislocation, sprain and strain of joints and ligaments of elbow

0.00

0.21

0.0

1.1

—

Cyst of kidney

0.00

0.21

0.0

1.0

—

Amputation of toe

0.00

0.21

0.0

1.0

—

Thyroiditis

0.00

0.21

0.0

1.0

—

Hydrocephalus

0.00

0.21

0.0

1.0

—

Divergent concomitant strabismus

0.00

0.21

0.0

1.1

—

Use of galantamine

0.00

0.21

0.0

1.0

—

Other and unspecified rosacea

0.00

0.21

0.0

1.0

—

Other sexually transmitted chlamydial diseases, including avohilmo

0.00

0.21

0.0

1.1

—

Diseases of arteries, arterioles and capillaries

146

0.85

0.21

1.1

—

Congenital malformations of genital organs

0.00

0.21

0.0

1.0

—

Pacemaker

0.77

0.21

1.3

1.1

—

Injury of muscle and tendon at shoulder and upper arm level

102

0.78

0.21

1.0

1.1

—

Migraine with aura

1.16

0.21

1.0

1.1

—

Renal failure

115

1.18

0.21

1.1

—

Gestational diabetes (for exclusion)

1.29

0.21

1.0

1.1

—

Other secondary gonarthrosis

0.00

0.21

0.0

1.0

—

Alcohol withdrawal state with delirium

0.00

0.21

0.0

1.2

—

Corns and callosities

0.00

0.21

0.0

1.0

—

Bleeding

169

0.87

0.20

1.1

—

Vascular dementia

0.00

0.20

0.0

1.0

—

Soft tissue disorders

140

0.88

0.20

1.1

—

Antihypertensive medication - note that there are other indications

1.18

0.20

1.0

1.1

—

Depression or dysthymia

0.84

0.20

1.1

—

Neuralgia and neuritis, unspecified

0.00

0.20

0.0

1.0

—

Other and unspecified psoriasis

0.00

0.20

0.0

1.0

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

0.00

0.20

0.0

1.0

—

Persistent delusional disorders

0.00

0.20

0.0

1.1

—

STROKE

112

0.84

0.20

1.1

—

Otitis externa

1.25

0.20

1.0

1.1

—

Substance abuse

144

0.84

0.20

1.1

—

Viral and other specified intestinal infections, including avohilmo

1.23

0.20

1.0

1.1

—

Atopic dermatitis, strict definition with reimbursement

1.20

0.19

1.0

1.1

—

Disorders of lens

119

1.15

0.19

1.2

1.1

—

Injuries to the thorax

133

0.83

0.19

1.1

—

Benign neoplasm of colon, rectum, anus and anal canal

155

1.14

0.19

1.2

1.1

—

Persons encountering health services in other circumstances

1.22

0.19

1.2

1.1

—

COPD

108

0.83

0.19

1.4

1.1

—

Presence of cardiac and vascular implants and grafts

0.82

0.19

1.2

1.1

—

Injuries to the hip and thigh

119

0.83

0.19

1.0

1.1

—

Polyp of the female genital tract

1.24

0.19

1.0

1.1

—

Postmenopausal bleeding

1.22

0.19

1.0

1.1

—

Visual disturbances and blindness

143

0.84

0.18

1.2

1.1

—

Other gastritis (incl. Duodenitis)

1.13

0.18

1.0

1.1

—

Cervicobrachial syndrome

1.13

0.18

1.0

1.1

—

Other and unspecified effects of external causes

1.13

0.18

1.7

1.1

—

Dislocation, sprain and strain of joints and ligaments of knee

139

0.84

0.18

1.1

—

Dyspnoea

174

1.12

0.18

1.1

—

Retinal detachments and breaks

100

1.20

0.18

1.1

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1.19

0.18

1.0

1.1

—

Rheumatoid arthritis

1.23

0.18

1.2

1.1

—

Continuous positive airway pressure

1.17

0.18

1.3

1.2

—

Early onset COPD

1.17

0.17

1.6

1.1

—

Diseases of the digestive system

118

1.18

0.17

1.1

—

Colonic or urogenital fistula

1.15

0.17

1.0

1.1

—

Acetic acid derivatives and related substances

1.22

0.17

1.1

1.2

—

Seropositive rheumatoid arthritis

0.76

0.17

1.0

—

Dizziness and giddiness

159

1.12

0.17

1.1

—

Other diseases of hard tissues of teeth

1.16

0.17

1.1

—

Other functional intestinal disorders

100

1.18

0.16

1.2

1.1

—

Sequelae of cerebrovascular disease

1.19

0.16

1.2

1.1

—

L02BG Aromatase inhibitors

1.16

0.16

1.1

1.0

—

Excessive attrition of teeth

147

1.14

0.16

1.0

1.1

—

Diseases of external ear

1.20

0.16

1.0

1.1

—

Injury, poisoning and certain other consequences of external causes

0.85

0.15

1.0

1.1

—

Infections with a predominantly sexual mode of transmission, including avohilmo

0.80

0.15

1.0

1.1

—

Obesity

149

1.14

0.15

1.1

—

Diseases of the ear and mastoid process

160

0.91

0.15

1.0

1.1

—

Primary coxarthrosis, bilateral

0.75

0.15

1.2

1.1

—

Nutritional anaemias

124

1.15

0.15

1.1

—

Infections of the skin and subcutaneous tissue

148

0.86

0.15

1.0

1.1

—

Other chronic obstructive pulmonary disease

106

0.85

0.15

1.4

1.1

—

Heart failure and antihypertensive medication

0.80

0.15

1.0

1.1

—

Chronic kidney disease

0.81

0.14

1.3

1.1

—

Obesity due to excess calories

112

1.16

0.14

1.1

—

Obesity and other hyperalimentation

150

1.13

0.14

1.1

—

Follow-up examination after treatment for conditions other than malignant neoplasms

1.17

0.14

1.1

1.2

—

Substance abuse, excluding more controls

125

0.87

0.14

1.1

—

Artificial joint operation, meniscal resection

169

0.91

0.13

1.3

1.1

—

Arthrosis

105

0.89

0.13

1.4

1.1

—

Degeneration of macula and posterior pole

109

1.13

0.13

1.1

—

Other cataract

1.14

0.12

1.1

—

Hard cardiovascular diseases

146

1.09

0.12

1.1

—

Triptan medication for migraine, single purchase ok

122

1.11

0.12

1.1

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

122

1.11

0.12

1.1

—

Other disorders of ear

169

0.92

0.11

1.0

1.1

—

Endocrine, nutritional and metabolic diseases

101

0.90

0.11

1.1

—

Coronary revascularization (ANGIO or CABG)

140

0.91

0.11

1.1

—

Missing teeth due to accident, extraction or parodontitis

159

0.90

0.11

1.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1.13

0.11

1.1

1.2

—

Unspecified haematuria

1.14

0.11

1.1

1.2

—

Mouth breathing

105

1.14

0.11

1.0

1.1

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

104

1.12

0.10

1.2

1.1

—

Hyperplasia of prostate

1.15

0.10

1.1

1.2

—

COPD, early/later onset

105

0.88

0.10

1.4

1.1

—

Unspecified fall

132

1.11

0.10

1.1

—

Hypothyroidism, other/unspecified

157

0.92

0.10

1.1

—

Inguinal hernia

102

1.11

0.10

1.1

1.2

—

Acute pancreatitis

1.14

0.10

1.2

1.1

—

Spondylopathies

123

0.91

0.10

1.1

—

Thyrotoxicosis

1.11

0.09

1.0

—

Other CVD

1.11

0.09

1.2

1.0

—

Senile cataract

111

1.09

0.09

1.2

1.1

—

COPD, hospital admissions

105

0.88

0.09

1.4

1.1

—

Female infertility, cervical, vaginal, other or unspecified origin

1.07

0.09

1.0

1.1

—

Benign neoplasm: Sigmoid colon

1.09

0.09

1.8

1.1

—

All anxiety disorders

112

1.11

0.09

1.0

1.1

—

Other diseases of lip and oral mucosa

114

0.88

0.09

1.0

1.1

—

Acute pancreatitis (for exclusion)

1.06

0.09

1.2

1.0

—

Effects of foreign body entering through natural orifice

1.07

0.08

1.2

1.1

—

Fall on and from stairs and steps

1.07

0.08

1.0

1.1

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

162

0.93

0.08

1.1

—

Menorrhagia

0.82

0.08

1.0

1.1

—

Major coronary heart disease event

148

0.93

0.08

1.1

—

Fibroblastic disorders

0.79

0.08

1.0

1.1

—

Aortic aneurysm

0.77

0.08

1.0

1.1

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

1.05

0.08

1.0

1.2

—

Other anxiety disorders

1.13

0.08

1.0

1.1

—

Other specified/unspecified arthritis

1.06

0.08

1.3

1.1

—

Other and unspecified tonsillitis

1.04

0.08

1.9

1.1

—

Injuries to the knee and lower leg

179

1.06

0.08

1.1

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

0.80

0.08

1.0

—

Injuries to the head

185

1.06

0.07

1.1

—

Impingement syndrome of shoulder

0.86

0.07

1.2

1.1

—

Gonarthrosis

1.08

0.07

1.2

1.1

—

Epilepsy

1.06

0.07

1.0

1.2

—

Other diseases of anus and rectum

1.06

0.07

1.3

1.1

—

Other hearing loss

1.05

0.07

1.1

—

Other enthesopathies

1.04

0.07

1.4

1.1

—

Medicines for HER+ breast cancer

1.03

0.07

1.1

1.0

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

107

1.11

0.07

1.2

1.1

—

Abnormal serum enzyme levels

0.83

0.07

1.0

1.2

—

Other arthritis (FG)

0.83

0.07

1.3

1.0

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

1.12

0.07

1.1

—

Fracture of rib(s), sternum and thoracic spine

0.82

0.07

1.0

1.1

—

Hernia of abdominal wall

122

0.90

0.07

1.0

1.1

—

Major coronary heart disease event excluding revascularizations

128

0.93

0.07

1.1

—

Contraceptive management

0.85

0.07

1.1

—

COPD, hospital admission 2, with asthma infections

0.88

0.07

1.5

1.1

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

0.86

0.06

1.0

1.1

—

Glucagon-like peptide-1 (GLP-1) analogues

0.86

0.06

1.0

1.1

—

Insulin, fast-acting or short human

0.85

0.06

1.4

1.1

—

Insulin, fast-acting

0.84

0.06

1.4

1.1

—

Other disorders of veins

100

0.89

0.06

1.1

—

Hyperlipidaemia, other/unspecified

100

0.90

0.06

1.1

—

Disorders of gallbladder, biliary tract and pancreas

171

1.05

0.06

1.0

1.1

—

COPD related to multimorbidity

0.90

0.06

1.0

1.1

—

Falls/tendency to fall

148

0.95

0.06

1.1

—

Gonarthrosis [arthrosis of knee](FG)

123

0.94

0.06

1.2

1.1

—

Heart failure, strict

123

1.07

0.06

1.1

—

Neurotic, stress-related and somatoform disorders

168

0.94

0.06

1.0

1.1

—

Diseases of oral cavity, salivary glands and jaws

1.08

0.06

1.1

—

Pregnancy with abortive outcome

0.91

0.06

1.0

1.1

—

Myocardial infarction

106

0.92

0.05

1.1

—

Visual disturbances

131

0.92

0.05

1.2

1.1

—

General examination and investigation of persons without complaint and reported diagnosis

1.08

0.05

1.0

1.2

—

Cholelithiasis

162

1.05

0.05

1.0

1.1

—

Iron deficiency anaemia

108

1.09

0.05

1.1

—

Other disorders of urethra and urinary system

119

0.93

0.04

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

123

1.08

0.04

1.0

1.1

—

Cardiac arrhythmias

102

1.07

0.04

1.1

—

Persons encountering health services in circumstances related to reproduction

0.93

0.04

1.2

1.1

—

Emergency coronary revascularization (for ACS)

152

0.95

0.04

1.1

—

Rheumatoid arthritis, including avohilmo

1.10

0.04

1.2

1.1

—

Dental operations

1.06

0.04

1.2

1.1

—

Open wound of head

141

1.07

0.04

1.0

1.1

—

Episodal and paroxysmal disorders

151

1.04

0.04

1.0

1.1

—

Hypothyroidism, strict autoimmune

118

0.94

0.03

1.1

—

Dermatophytosis, including avohilmo

167

1.06

0.03

1.1

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

145

0.94

0.03

1.0

1.1

—

Percutaneous Coronary Intervention

140

0.96

0.03

1.0

1.1

—

Heart failure,strict

112

1.06

0.03

1.1

—

External causes of morbidity and mortality

0.94

0.03

1.1

—

Benign neoplasm: Colon

149

0.94

0.03

1.3

1.1

—

Cervical disc disorders

1.09

0.03

1.2

1.1

—

Excessive earwax

162

0.95

0.03

1.0

1.1

—

Mood disorders

185

0.97

0.02

1.1

—

Fracture of lower leg, including ankle

149

1.05

0.02

1.1

—

Pain in limb

139

0.96

0.02

1.1

—

Exposure to unspecified factor

191

1.03

0.02

1.1

—

Other nutritional deficiencies

157

1.05

0.02

1.1

—

Ischemic heart diseases

142

0.96

0.02

1.0

1.1

—

Other arrhythmias

121

1.05

0.02

1.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

152

1.05

0.02

1.1

—

Retention of urine

1.08

0.02

1.1

1.2

—

Psychiatric diseases

141

1.03

0.01

1.1

—

Disorders of the thyroid gland

167

0.97

0.01

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

172

1.03

0.01

1.1

—

Other retinal disorders

142

0.96

0.01

1.1

—

Mood [affective] disorders

184

0.97

0.01

1.1

—

Anxiety disorders, excluding more controls

145

0.97

0.01

1.0

1.1

—

Myocardial infarction, without ST-elevation

105

0.94

0.01

1.1

1.2

—

Necrosis of pulp, including avohilmo

142

1.04

0.01

1.3

1.1

—

Constipation

167

0.97

0.01

1.0

1.1

—

Arthropathies

118

1.03

0.00

1.1

—

Fracture of forearm

128

0.98

0.00

1.1

—

Depression

178

1.01

0.00

1.1

—

Spondylosis

113

0.97

0.00

1.0

1.1

—

Disease of hard tissues of teeth, NOS

1.00

0.00

1.0

1.1

—

Dentofacial anomalies [including malocclusion]

132

1.01

0.00

1.0

1.1

—

Other symptoms and signs involving cognitive functions and awareness

125

0.99

0.00

1.1

—

Mood disorders, excluding more controls

156

0.98

0.00

1.1

—

Spinal stenosis

103

1.00

0.00

1.0

1.1

—

Medical abortion

1.04

0.00

1.0

1.1

—

Cerebrovascular diseases

152

1.00

0.00

1.1

—

Inflammatory diseases of female pelvic organs

1.04

0.00

1.1

1.0

—

Anxiety (asthma-related co-morbidities)

118

1.03

0.00

1.0

1.1

—

Transport accidents

0.99

0.00

1.1

—

Neurological diseases

116

1.00

0.00

1.0

1.2

—

Cholelithiasis, broad definition with cholecystitis

163

1.02

0.00

1.0

1.1

—

All-cause Heart Failure

122

1.03

0.00

1.1

—

Any mental disorder

157

0.99

0.00

1.1

—

Anxiety disorders

168

0.98

0.00

1.0

1.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

174

1.00

0.00

1.0

1.1

—

Myocardial infarction, strict

0.96

0.00

1.1

1.2

—

Diseases of male genital organs

0.97

0.00

1.1

1.2

—

Open wound of wrist and hand

121

1.04

0.00

1.0

1.1

—

Cholecystectomy

165

1.03

0.00

1.0

1.1

—

Cirrhosis of liver, NAS

0.00

0.0

1.0

—

Heart failure and bmi 25plus

0.98

0.00

1.1

—

Chronic tubulo-interstitial nephritis

0.00

0.0

1.0

—

Suicide or other Intentional self-harm

0.98

0.00

1.0

1.1

—

Gluteal tendinitis

0.00

0.0

1.0

—

Other and unspecified injuries of wrist and hand

0.00

0.0

1.0

—

Rubella [German measles]

0.00

0.0

2.0

—

Other disorders of pigmentation

0.00

0.0

1.0

—

Pericarditis

0.00

0.0

1.0

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

0.93

0.00

1.0

1.1

—

Other and unspecified intracranial injuries

0.00

0.0

1.0

—

Hypertrophic disorders of skin

0.00

0.0

1.0

—

Status epilepticus

0.00

0.0

1.0

—

Fracture of shoulder and upper arm

0.98

0.00

1.0

1.1

—

Other inflammation of vagina/vulva

0.00

0.0

1.0

—

Extreme obesity with alveolar hypoventilation

0.00

0.0

1.0

—

Tobacco use

0.00

0.0

1.0

—

Contact with heat and hot substances

0.00

0.0

1.0

—

Volvulus

0.00

0.0

1.0

—

Endovascular or surgical operations to intracerebral aneurysms

0.00

0.0

1.0

—

Maternal care for known or suspected disproportion

0.00

0.0

1.0

—

Lesion of plantar nerve

0.00

-0.00

0.0

1.0

—

Excessive, frequent and irregular menstruation

0.87

-0.00

1.0

1.1

—

Hypogonadotropic hypogonadism

0.00

-0.00

0.0

1.3

—

Spontaneous abortion

1.00

-0.00

1.0

1.1

—

Haemorrhoids and perianal venous thrombosis

0.90

-0.00

1.4

1.1

—

Gonococcal infection, including avohilmo

0.00

-0.00

0.0

1.0

—

Systemic atrophies primarily affecting the central nervous system

0.00

-0.00

0.0

1.0

—

Atrial fibrillation and flutter

0.97

-0.00

1.1

1.2

—

Deforming dorsopathies

1.00

-0.00

1.0

1.1

—

Lesion of sciatic nerve

0.00

-0.00

0.0

1.0

—

Conduction disorders

0.92

-0.00

1.1

1.2

—

Alzheimer’s disease (Early onset)

0.00

-0.00

0.0

1.0

—

Intrahepatic Cholestasis of Pregnancy (ICP)

0.00

-0.00

0.0

1.0

—

Lactose intolerance

0.00

-0.00

0.0

1.0

—

Congenital ovarian cysts

0.00

-0.00

0.0

1.0

—

Hypertensive heart and/or renal disease

0.88

-0.00

1.6

1.2

—

Trigeminal neuralgia

0.00

-0.00

0.0

1.0

—

Abnormal findings on antenatal screening of mother

0.00

-0.00

0.0

1.0

—

Specific development disorders of speech and language

0.00

-0.00

0.0

1.0

—

Hyperfunction of pituitary gland

0.00

-0.00

0.0

1.0

—

Other neurotic disorders

0.00

-0.00

0.0

1.0

—

Injuries involving multiple body regions

0.00

-0.00

0.0

1.0

—

Other or ill-defined heart diseases

0.00

-0.00

0.0

1.0

—

Other disorders of adrenal gland

0.00

-0.00

0.0

1.0

—

Labour and delivery complicated by umbilical cord complications

0.00

-0.00

0.0

1.0

—

Superficial injuries involving multiple body regions

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Skin of ear and external auricular canal

0.00

-0.00

0.0

1.0

—

Other sexually transmitted chlamydial diseases

0.00

-0.00

0.0

1.0

—

Other acquired deformities of musculoskeletal system and connective tissue

0.00

-0.00

0.0

1.0

—

Other salmonella infections

0.00

-0.00

0.0

1.0

—

Fracture of femur

0.93

-0.00

1.0

1.1

—

Atopic dermatitis, strict definition

0.98

-0.00

1.0

1.1

—

Type1 diabetes, definitions combined, early onset

0.00

-0.00

0.0

1.0

—

Type 1 diabetes, wide definition

0.96

-0.00

1.2

—

Other pulmonary heart/vessel disease

0.00

-0.00

0.0

1.0

—

Oral lichen planus

0.00

-0.00

0.0

1.0

—

Emotional disorders starting during childhood or adolescence

0.00

-0.00

0.0

1.0

—

Follow-up care involving plastic surgery

0.00

-0.00

0.0

1.0

—

Speech and linguistic disorders, excluding more controls

0.00

-0.00

0.0

1.0

—

Other surgical follow-up care

0.00

-0.00

0.0

1.0

—

Subacute thyroiditis

0.00

-0.00

0.0

1.0

—

Fall involving bed

0.00

-0.00

0.0

1.0

—

Attention to artificial openings

0.00

-0.00

0.0

1.0

—

Caught, crushed, jammed or pinched in or between objects

0.00

-0.00

0.0

1.0

—

Sub-endpoint used in defining T1D endpoints

0.97

-0.00

1.2

1.1

—

Type 1 diabetes, wide definition, subgroup 1

1.02

-0.00

1.2

1.1

—

Injury of nerves at wrist and hand level

0.00

-0.00

0.0

1.0

—

Toxic effect of ethanol

0.00

-0.00

0.0

1.0

—

Dislocation, sprain and strain of joints and ligaments of head

0.00

-0.00

0.0

1.0

—

Other diseases of gallbladder

0.00

-0.00

0.0

1.0

—

Dislocation, sprain and strain of joints and ligaments of thorax

0.00

-0.00

0.0

1.0

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

0.91

-0.00

1.0

1.2

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

0.91

-0.00

1.3

1.1

—

Other/unspecified seropositive rheumatoid arthritis

0.91

-0.00

1.0

1.1

—

Intestinal malabsorption

0.00

-0.00

0.0

1.0

—

Other and unspecified abdominal hernia

0.00

-0.00

0.0

1.0

—

Systemic sclerosis (FG)

0.00

-0.00

0.0

1.0

—

Paralytic ileus

0.00

-0.00

0.0

1.0

—

Superficial injury of lower leg

0.89

-0.00

1.0

—

Abnormalities of heart beat

0.99

-0.00

1.1

—

Other epidermal thickening

0.00

-0.00

0.0

1.0

—

Urticaria

1.02

-0.00

1.0

1.1

—

L02BX Other hormone antagonists and related agents

0.00

-0.00

0.0

1.0

—

L01XE Protein kinase inhibitors

0.00

-0.00

0.0

1.0

—

Other secondary coxarthrosis

0.00

-0.00

0.0

1.0

—

Internal derangement of knee

0.98

-0.00

1.1

—

Coxibs

0.87

-0.00

1.2

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

0.92

-0.00

1.0

1.2

—

Moderate visual impairment, binocular

0.00

-0.00

0.0

1.0

—

Disturbances of smell and taste

0.00

-0.00

0.0

1.0

—

Abnormal findings on examination of urine, without diagnosis

0.00

-0.00

0.0

1.0

—

Use of biperiden

0.00

-0.00

0.0

1.0

—

Use of ropinirole

0.00

-0.00

0.0

1.0

—

Use of selegiline

0.00

-0.00

0.0

1.0

—

Use of rasagiline

0.00

-0.00

0.0

1.0

—

Uterine polyps

0.91

-0.00

1.0

1.1

—

Pregnancy hypertension

0.89

-0.00

1.0

—

Total colectomy operation

0.00

-0.00

0.0

1.0

—

Placenta praevia

0.00

-0.00

0.0

1.0

—

Adrenocortical insufficiency

0.00

-0.00

0.0

1.0

—

Failed induction of labour

0.00

-0.00

0.0

1.0

—

Total colectomy

0.00

-0.00

0.0

1.0

—

Other noninflammatory disorders of cervix uteri

0.00

-0.00

0.0

1.1

—

Unspecified abortion

0.00

-0.00

0.0

1.1

—

Chondrocostal junction syndrome [Tietze]

0.00

-0.00

0.0

1.0

—

Monoarthritis, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Other specified disorders of muscle

0.00

-0.00

0.0

1.0

—

Morphin

0.00

-0.00

0.0

1.0

—

Bursitis of shoulder

0.00

-0.00

0.0

1.0

—

Other and unspecified disease of Bartholin gland

0.00

-0.00

0.0

1.0

—

Female infertility

0.97

-0.00

1.0

1.1

—

Erosion and ectropion of cervix uteri

0.00

-0.00

0.0

1.0

—

Female genital prolapse

0.90

-0.00

1.0

1.1

—

Female infertility, associated with anovulation

0.00

-0.00

0.0

1.2

—

Scar conditions and fibrosis of skin

0.00

-0.00

0.0

1.0

—

Impotence

0.00

-0.00

0.0

1.1

—

Other menopausal disorders

0.87

-0.00

1.0

1.1

—

Primary angle-closure glaucoma

0.00

-0.00

0.0

1.0

—

Cervicalgia

0.94

-0.00

1.0

1.1

—

Speech and linguistic disorders

0.00

-0.00

0.0

1.0

—

Acute generalized exanthematous pustulosis

0.00

-0.00

0.0

1.0

—

Diseases of tongue

0.00

-0.00

0.0

1.0

—

Other diseases of peritoneum

0.00

-0.00

0.0

1.0

—

Hypertrophic scar

0.00

-0.00

0.0

1.0

—

Open bite

0.00

-0.00

0.0

1.0

—

Seropositive rheumatoid arthritis, wide

0.91

-0.00

1.0

1.1

—

Cysts of oral region, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Rectosigmoid junction

0.00

-0.00

0.0

1.0

—

GI-bleeding

0.90

-0.00

1.1

—

Unspecified chronic bronchitis

0.00

-0.00

0.0

1.0

—

Pyothorax

0.00

-0.00

0.0

1.0

—

Sequelae of other and unspecified infectious and parasitic diseases

0.00

-0.00

0.0

1.1

—

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

0.00

-0.00

0.0

1.1

—

Endocarditis

0.00

-0.00

0.0

1.0

—

Arterial embolism and thrombosis of lower extremity artery

0.00

-0.00

0.0

1.0

—

Secondary right heart disease

0.00

-0.00

0.0

1.0

—

Vascular syndromes of brain in cerebrovascular disorders

0.00

-0.00

0.0

1.0

—

Generalized skin eruption due to drugs and medicaments

0.00

-0.00

0.0

1.0

—

Strabismus

0.98

-0.00

1.0

1.1

—

Other obstetric trauma

0.00

-0.00

0.0

1.0

—

Herpesviral keratitis and keratoconjunctivitis

0.00

-0.00

0.0

1.0

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

Convergent concomitant strabismus

0.00

-0.00

0.0

1.0

—

Lesion of lateral popliteal nerve

0.00

-0.00

0.0

1.0

—

Cluster headache, strict, including avohilmo

0.00

-0.00

0.0

1.1

—

Cluster headache, strict

0.00

-0.00

0.0

1.2

—

Cluster headache, wide

0.00

-0.00

0.0

1.2

—

Colorectal adenocarcinoma

0.00

-0.00

0.0

1.0

—

Type 1 diabetes

0.94

-0.00

1.2

1.1

—

Normal-pressure hydrocephalus

0.00

-0.00

0.0

1.0

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

0.94

-0.00

1.6

1.1

—

Other benign neoplasm of uterus: Other parts/unspecified

0.00

-0.00

0.0

1.0

—

Acute posthaemorrhagic anaemia

0.00

-0.00

0.0

1.0

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

0.00

-0.00

0.0

1.1

—

Arthropathies in other diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Colon, unspecified

0.91

-0.00

1.2

1.1

—

Other salmonella infections, including avohilmo

0.00

-0.00

0.0

1.0

—

Optic neuritis

0.00

-0.00

0.0

1.0

—

Other congenital malformations of the digestive system, including avohilmo

0.00

-0.00

0.0

1.0

—

Rubella [German measles], including avohilmo

0.00

-0.00

0.0

2.0

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

0.00

-0.00

0.0

1.0

—

Sequelae of external causes of morbidity and mortality

0.85

-0.00

1.0

1.1

—

Infections with a predominantly sexual mode of transmission

0.89

-0.00

1.0

1.1

—

Cluster headache, wide,, including avohilmo

0.00

-0.00

0.0

1.1

—

Gonococcal infection

0.00

-0.00

0.0

1.0

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS